The Dynamics of Chronic Gout Treatment: Medication Gaps and Return to Therapy

Meyers Primary Care Institute, Worcester, Mass., USA.
The American journal of medicine (Impact Factor: 5). 01/2010; 123(1):54-9. DOI: 10.1016/j.amjmed.2009.05.026
Source: PubMed


To identify gaps in therapy with urate-lowering drugs for the treatment of gout as well as factors associated with resuming therapy.
From 2 integrated delivery systems, we identified patients 18 years or older with a diagnosis of gout who initiated use of a urate-lowering drug from January 1, 2000 through June 30, 2006 and who had a gap in therapy. A gap was defined as a period of over 60 days after the completion of 1 prescription in which no refill for a urate-lowering drug was obtained. Survival curves were used to assess return to therapy of urate-lowering drugs. Cox proportional hazards analysis estimated the association between covariates and return to therapy.
There were 4166 new users of urate-lowering drugs (97% received allopurinol), of whom 2929 (70%) had a gap in therapy. Among those with a gap, in 75% it occurred in the first year of therapy. Fifty percent of patients with a gap returned to therapy within 8 months, and by 4 years it was 75%. Age 45-74 years (<45 referent) and greater duration of urate-lowering drug use before the gap was associated with resuming treatment within 1 year. In contrast, receipt of nonsteroidal anti-inflammatory drugs or glucocorticoids in the year before the gap was associated with a reduced likelihood of resuming therapy.
The majority of gout patients with gaps in urate-lowering drug use returned to treatment. More investigation is needed to better understand why patients may go for months without refilling prescriptions, given the clinical consequences of nonadherence.

Download full-text


Available from: Marsha A Raebel, Feb 06, 2014
  • Source
    • "In this study, lack of awareness regarding the need for chronic therapy with urate-lowering medications as well as short-term risk of acute gout symptoms with initiation of this class of medications may help explain the results of larger epidemiologic studies, specifically that most patients who initiate a urate-lowering medication have large gaps in drug use over the first year [14-17] with most returning to treatment over the next 4 years [27]. While interruptions in medication drug use commonly occur due to financial concerns or side effects, it is less likely these factors played a role given the availability of generic medications with modest copayments and that most patients eventually restarted their prior urate-lowering medication. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background For patients to effectively manage gout, they need to be aware of the impact of diet, alcohol use, and medications on their condition. We sought to examine patients’ knowledge and beliefs concerning gout and its treatment in order to identify barriers to optimal patient self-management. Methods We identified patients (≥18 years of age) cared for in the setting of a multispecialty group practice with documentation of at least one health care encounter associated with a gout diagnosis during the period 2008–2009 (n = 1346). Patients were sent a questionnaire assessing knowledge with regard to gout, beliefs about prescription medications used to treat gout, and trust in the physician. Administrative electronic health records were used to identify prescription drug use and health care utilization. Results Two hundred and forty patients returned surveys out of the 500 contacted for participation. Most were male (80%), white (94%), and aged 65 and older (66%). Only 14 (6%) patients were treated by a rheumatologist. Only a minority of patients were aware of common foods known to trigger gout (e.g., seafood [23%], beef [22%], pork [7%], and beer [43%]). Of those receiving a urate-lowering medication, only 12% were aware of the short-term risks of worsening gout with initiation. These deficits were more common in those with active as compared to inactive gout. Conclusion Knowledge deficits about dietary triggers and chronic medications were common, but worse in those with active gout. More attention is needed on patient education on gout and self-management training.
    Full-text · Article · Sep 2012 · BMC Musculoskeletal Disorders
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A p-channel poly-Si CMTFT (Conductivity Modulated Thin-Film Transistor) is demonstrated and experimentally characterized. The transistor uses the concept of conductivity modulation in the offset region to obtain a significant reduction in on-state resistance. This structure can provide 1.5 to 2 orders of magnitude higher on-state current than that of the conventional offset drain TFT at drain voltage ranging from -15 V to -5 V while still maintaining low leakage current and simplicity in device operation. The p-channel CMTFT can be combined with the n-channel CMTFT to form CMOS high voltage drivers, which are very suitable for use in fully integrated large area electronic applications
    Preview · Conference Paper · Feb 1999
  • [Show abstract] [Hide abstract]
    ABSTRACT: Software quality modeling can be used by a software maintenance project to identify a limited set of software modules that probably need improvement. A model's goal is to recommend a set of modules to receive special treatment. The purpose of the paper is to report our experiences modeling software quality with classification trees, including necessary preprocessing of data. We conducted a case study on two releases of a very large legacy telecommunications system. A module was considered fault-prone if any faults were discovered by customers, and not fault-prone otherwise. Software product, process, and execution metrics were the basis for predictors. The TREEDISC algorithm for building classification trees was investigated, because it emphasizes statistical significance. Numeric data, such as software metrics, are not suitable for TREEDISC. Consequently, we transformed measurements into discrete ordinal predictors by grouping. This case study investigated the sensitivity of modeling results to various groupings. We found that robustness, accuracy, and parsimony of the models were influenced by the maximum number of groups. Models based on two sets of candidate predictors had similar sensitivity
    No preview · Conference Paper · Feb 1999
Show more